1. Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study. Issue 1 (25th June 2021) Authors: Hompesch, Marcus; Kang, Jahoon; Han, OakPil; Trautmann, Michael E; Sorli, Christopher H; Ogbaa, Ike; Stewart, John; Morrow, Linda Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline. Issue 1 (18th January 2022) Authors: Pratley, Richard E; Jacob, Stephan; Baek, Seungjae; Trautmann, Michael E; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H; Shaunik, Alka; Yoon, Kun-Ho Journal: BMJ open diabetes research and care Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗